PolarisQB is utilizing Quantum Computing, Artificial Intelligence, Machine Learning and Personalized Medicine to Revolutionize Drug Design. By compressing the lead time for pre-clinical drug candidates from 5 years to 4 months, we will produce up to 100 drug blueprints per year, enabling real time adaptability within the precision medicine market. Using these methodologies, Polaris will build an IP portfolio of drug assets to license, sell, or develop internally.
Location: United States
Employees: 11-50
Total raised: $2.1M
Founded date: 2020
Founders name: Bill Shipman; Shahar Keinan
Investors 1
| Date | Name | Website |
| - | WorldQuant... | worldquant... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.08.2021 | Seed | $2.1M | - |
Persons 6
| Date | First Name | Last Name | Title | Location | |||
| - | Bill | Shipman | CTO and co... | linkedin.c... | - | b******n@p... | - |
| - | Kendall | Byler | Computatio... | linkedin.c... | - | k****r@pol... | - |
| - | Denise | Richards | Director o... | linkedin.c... | - | d*******s@... | - |
| - | Galina | Yatsenko | Intern | linkedin.c... | - | g*******o@... | - |
| - | Will | Simpson | Director O... | linkedin.c... | - | w******n@p... | - |
| - | Shahar | Keinan | CEO and co... | linkedin.c... | - | S*****n@po... | - |
Mentions in press and media 6
| Date | Title | Description |
| 12.08.2024 | PolarisQB Announces Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design | PolarisQB announce integration of Virtual Libraries and Fragmentation schemes from chemical innovator Liverpool ChiroChem into Quantum-Aided Drug Design (QuADD) Liverpool ChiroChem ULVL chiral molecules can now be accurately identified in Q... |
| 04.01.2024 | POLARISqb and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design | Quantum-Aided Drug Design, a new SaaS from POLARISqb, generates optimized molecular libraries at quantum speed. POLARISqb and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discover... |
| 27.06.2023 | POLARISqb New SaaS, Quantum-Aided Drug Design (QuADD) Demonstrates Advantage Versus Traditional Library Builds | Quantum-Aided Drug Design, a new SaaS from POLARISqb, generates optimized molecular libraries at quantum speed. POLARISqb, the first company in the world to develop a drug discovery platform for a quantum computer, is releasing a Software a... |
| 11.04.2023 | POLARISqb Demonstrates Menu Optimization via Constrained Quadratic Model on D-Wave Annealing Quantum Computer | POLARISqb has published a white paper that demonstrates quantum annealing-based optimization using a Constrained Quadratic Model, or CQM. DURHAM, NC, USA, April 11, 2023/EINPresswire.com/ -- The scientists at POLARISqb designed and engineer... |
| 09.08.2022 | POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI | POLARISqb and Auransa Partner to Tackle Women's Health Issues Auransa, Inc.,an AI biotech and Polaris Quantum Biotech (Polarisqb), a quantum based drug design company, announce progress on important breast cancer target. PALO ALTO, CA, DURH... |
| 02.09.2021 | Startups should look to state-of-the-art tech to tackle diseases affecting women | Shahar Keinan Contributor Share on Twitter Shahar Keinan, co-founder and CEO of Polaris Quantum Biotech has over 20 years of extensive experience in computational and theoretical chemistry. Pek Lum Contributor Share on Twitter Pek Lum, co-f... |